Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Blind clinical trials levels

This was a multi-centre, pan-European, randomised double-blind placebo-controlled clinical trial in acute stroke to evaluate the effect of ancrod, a natural defribrinogenating agent (Hennerici et al. (2006)). The primary endpoint was based on the Barthel Index a favourable score of 95 or 100 or a return to the pre-stroke level at three months was viewed as a success. The primary method of statistical analysis was based on a logistic model including terms for treatment, age category, baseline Scandinavian Stroke Scale and centre. [Pg.223]

Ryberg H, Askmark H, Persson L (2003) A double blind randomized clinical trial in amyotrophic lateral sclerosis using lamotrigine Effects on CSE glutamate, aspartate, branched chain amino acid levels and clinical parameters. Acta Neurol Scand 108 1-8. [Pg.587]

See other pages where Blind clinical trials levels is mentioned: [Pg.117]    [Pg.51]    [Pg.377]    [Pg.100]    [Pg.99]    [Pg.1368]    [Pg.1466]    [Pg.122]    [Pg.324]    [Pg.134]    [Pg.654]    [Pg.314]    [Pg.169]    [Pg.90]    [Pg.485]    [Pg.882]    [Pg.11]    [Pg.105]    [Pg.107]    [Pg.285]    [Pg.26]    [Pg.584]    [Pg.722]    [Pg.165]    [Pg.128]    [Pg.193]    [Pg.434]    [Pg.210]    [Pg.68]    [Pg.299]    [Pg.296]    [Pg.1470]    [Pg.580]    [Pg.82]    [Pg.79]    [Pg.111]    [Pg.231]    [Pg.304]    [Pg.3]    [Pg.457]    [Pg.121]    [Pg.123]    [Pg.314]    [Pg.275]    [Pg.997]    [Pg.903]    [Pg.767]    [Pg.1124]    [Pg.397]   


SEARCH



Blind

Blinded trials

Blinding

Blinding blinded trials

Clinical trials blinding

Clinical trials blindness

© 2024 chempedia.info